Загрузка...
Targeted and Immune-based Therapies for Hepatocellular Carcinoma
Treatment options for patients with hepatocellular carcinoma (HCC) are rapidly changing based on positive results from phase 3 trials of targeted and immune-based therapies. More agents designed to target specific pathways and immune checkpoints are in clinical development. Some agents have already...
Сохранить в:
| Опубликовано в: : | Gastroenterology |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6340758/ https://ncbi.nlm.nih.gov/pubmed/30287171 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.gastro.2018.09.051 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|